Please provide your email address to receive an email when new articles are posted on . Prevent Blindness has declared Sept. 16 to 22 as Inflammatory Eye Disease Awareness Week and is offering free ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The middle layer of the eye, known as the uvea, becomes inflamed when someone has eye inflammation or uveitis.

Despite their side-effects and the advent of systemic immunosuppressives and biologics, the use of corticosteroids remains in the management of patients with uveitis, particularly when inflammation is ...

Research has suggested that GLP-1 receptor agonists may have protective effects against certain eye conditions, but they have also been linked to rare ophthalmic complications. In this retrospective ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The MarketWatch News Department was not involved in the creation of this content. Vyome's offering is a first-of-its-kind in a broader $20B potential addressable ocular inflammation market VT-1908 ...

Uveitis, or inflammation of the eye's uvea area beneath the white of the eye, is a rare disease that has proven challenging to diagnose and monitor. A team from University Hospital Bonn (UKB) and ...

“I could hardly see,” she recalled. “I was losing my vision and nobody was able to tell me why,” she told ABC. The source of the problem was not in her eyes at all. It was a tattoo on her back, inked ...